242 related articles for article (PubMed ID: 20422398)
1. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury.
Lim AK; Ma FY; Nikolic-Paterson DJ; Kitching AR; Thomas MC; Tesch GH
Diabetologia; 2010 Aug; 53(8):1772-82. PubMed ID: 20422398
[TBL] [Abstract][Full Text] [Related]
2. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
4. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
5. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
[TBL] [Abstract][Full Text] [Related]
6. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.
Chow FY; Nikolic-Paterson DJ; Ozols E; Atkins RC; Rollin BJ; Tesch GH
Kidney Int; 2006 Jan; 69(1):73-80. PubMed ID: 16374426
[TBL] [Abstract][Full Text] [Related]
8. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Cyclooxygenase-2 Protects Against Development of Diabetic Nephropathy.
Wang X; Yao B; Wang Y; Fan X; Wang S; Niu A; Yang H; Fogo A; Zhang MZ; Harris RC
Diabetes; 2017 Feb; 66(2):494-504. PubMed ID: 27815317
[TBL] [Abstract][Full Text] [Related]
10. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
12. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.
Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141
[TBL] [Abstract][Full Text] [Related]
13. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
[TBL] [Abstract][Full Text] [Related]
14. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
15. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
17. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
[TBL] [Abstract][Full Text] [Related]
18. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.
Ma J; Chadban SJ; Zhao CY; Chen X; Kwan T; Panchapakesan U; Pollock CA; Wu H
PLoS One; 2014; 9(5):e97985. PubMed ID: 24842252
[TBL] [Abstract][Full Text] [Related]
19. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice.
Lim AK; Nikolic-Paterson DJ; Ma FY; Ozols E; Thomas MC; Flavell RA; Davis RJ; Tesch GH
Diabetologia; 2009 Feb; 52(2):347-58. PubMed ID: 19066844
[TBL] [Abstract][Full Text] [Related]
20. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
